Latest updates you need to know, quick, clear, and to the point.
FDA approval based on superiority of Gazyva/Gazyvaro over standard therapy alone, as shown in phase II NOBILITY and...
https://www.afro.who.int/news/last-ebola-patient-democratic-republic-congo-discharged 19 October 2025 / Bulape – The last Ebola patient in the Democratic Republic of the Congo was discharged...
Giredestrant plus everolimus reduced the risk of disease progression or death by 44% and 62% in ITT and ESR1-mutated...
Vamikibart is the first non-steroid targeted therapy designed to address inflammation driving UME and may offer a potential...
Positive recommendation based on phase II NOBILITY and phase III REGENCY data showing Gazyva/Gazyvaro’s superiority over standard therapy alone1,2...
Significant progress in bulk RNA sequencing, methylation mapping, multiomics integration, and spatial analyses unlocks research previously out of...
14 October 2025 -- Geneva, Seoul -- The World Health Organization (WHO) today warns that less than one...
Increased commitment to preparedness and investment in primary health care and risk monitoring essential to protect world from...
Basel, 13 October 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it will present more...
Substandard (contaminated) oral liquid medicines identified in the WHO South-East Asia Region Geneva, 13 October 2025 Alert summary...
Berlin- 13 October 2025 -- Today, the World Health Organization (WHO), in collaboration with key partners and supporters, launched version...
Geneva - 13 October 2025 -- In a landmark public health achievement, the World Health Organization (WHO) has validated the...